All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

TRT monitoring: what follow-up labs actually catch and why

Rena Malik, MD

TikTok creator

29.2K viewsWatch on TikTok→

Quick answer

Dr. Malik accurately describes three well-documented side effect pathways of testosterone replacement therapy: androgen-driven sebaceous activity causing acne, aromatase-mediated conversion of testosterone to estradiol contributing to gynecomastia, and DHT-driven acceleration of androgenetic alopecia in genetically predisposed men. Her recommendation for routine bloodwork monitoring aligns with Endocrine Society guidelines, which specify testosterone level checks at 3 and 6 months post-initiation and annually thereafter. The video does not address hematocrit monitoring, which carries clinically significant cardiovascular implications and is a standard component of TRT follow-up panels.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @renamalikmd actually say?

The video makes four main claims: regular blood monitoring is necessary even when you feel fine on TRT; acne and oily skin are real but non-threatening side effects; testosterone converts to estradiol in the blood, which can cause gynecomastia; and hair loss is a genuine risk, especially for men who are genetically predisposed to male pattern baldness.

Dr. Malik frames these as routine side effects worth watching, not emergencies. The tone is practical, not alarmist. She tells viewers that gynecomastia "may require either changing of doses or addition of other medications" and that TRT "may expedite hair loss" rather than cause it from scratch. Those are meaningfully different claims, and the distinction matters.

Does the science back this up?

Mostly yes. The mechanisms described here are well-established, and the monitoring recommendation is consistent with clinical guidelines. Where things get slightly blurry is in the hair loss framing.

On monitoring: the Endocrine Society's 2018 clinical practice guidelines (Bhasin et al., Journal of Clinical Endocrinology and Metabolism) explicitly recommend checking testosterone levels at 3 and 6 months after initiation, then annually. Skipping labs because you feel fine is exactly the kind of mistake those guidelines exist to prevent. Hematocrit, PSA, and lipids are also on that monitoring list, none of which produce symptoms until something has already gone wrong.

On gynecomastia: the testosterone-to-estradiol aromatization pathway is textbook endocrinology. Aromatase enzyme converts testosterone to estradiol, and supraphysiologic or poorly-managed levels can push estrogen high enough to stimulate breast tissue. Rhoden and Morgentaler (2004, New England Journal of Medicine) documented this pathway clearly in their review of TRT risks.

On hair loss: the DHT connection is real. 5-alpha reductase converts testosterone to dihydrotestosterone, and DHT is the primary driver of androgenetic alopecia. Kaufman and Dawber (1999, Journal of Investigative Dermatology) confirmed this mechanism. The word "expedite" is actually the right word here, which is worth noting.

What did they get wrong (or right)?

Credit where it is due: the aromatization explanation is accurate and genuinely useful for patients who have never understood why a testosterone treatment could cause breast changes. Most short-form health content skips the mechanism entirely. She did not.

The hair loss section deserves a small flag, though. Saying "check out my prior video" is not a substitute for explaining the DHT mechanism in this one. A viewer with no prior context might walk away thinking testosterone directly attacks hair follicles, when the actual pathway runs through DHT conversion, a distinction that matters because 5-alpha reductase inhibitors exist as a management option. That omission is not wrong, but it is incomplete.

The acne claim is accurate but thin. Sebaceous gland stimulation by androgens is well-documented (Thiboutot, 2004, Journal of the American Academy of Dermatology), and calling it "not life threatening but bothersome" is fair. She could have mentioned that severe acne cases sometimes require dermatology referral, but that is a missed addition rather than an error.

What should you actually know?

If you are on TRT, the monitoring message here is probably the most important thing in this video. Blood levels alone are not enough. Standard follow-up panels for TRT typically include total and free testosterone, estradiol, hematocrit, PSA, and sometimes a lipid panel. Elevated hematocrit in particular can increase clotting risk and produces zero symptoms until the problem is serious.

Gynecomastia does not happen to everyone, and it is not inevitable. Aromatization rates vary considerably between individuals based on body composition and genetics. If it does occur, the management options Dr. Malik references are real, but those decisions belong in a conversation with a prescribing clinician, not a TikTok comment section.

On hair loss: if male pattern baldness runs in your family and you are considering TRT, this is a conversation worth having before you start, not after you notice thinning. The "genetically predisposed" framing here is accurate. TRT does not give you a gene you did not have. It can, however, accelerate a process that was already written into your biology.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For TRT monitoring: what follow-up labs actually catch and why, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

TRT monitoring: what follow-up labs actually catch and why is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Dr.

FormBlends verdict

Dr. Malik accurately describes three well-documented side effect pathways of testosterone replacement therapy: androgen-driven sebaceous activity causing acne, aromatase-mediated conversion of testosterone to estradiol contributing to gynecomastia, and DHT-driven acceleration of androgenetic alopecia in genetically predisposed men. Her recommendation for routine bloodwork monitoring aligns with Endocrine Society guidelines, which specify testosterone level checks at 3 and 6 months post-initiation and annually thereafter. The video does not address hematocrit monitoring, which carries clinically significant cardiovascular implications and is a standard component of TRT follow-up panels.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Dr. Malik accurately describes three well-documented side effect pathways of testosterone replacement therapy: androgen-driven sebaceous activity causing acne, aromatase-mediated conversion of testosterone to estradiol contributing to gynecomastia, and DHT-driven acceleration of androgenetic alopecia in genetically predisposed men. Her recommendation for routine bloodwork monitoring aligns with Endocrine Society guidelines, which specify testosterone level checks at 3 and 6 months post-initiation and annually thereafter. The video does not address hematocrit monitoring, which carries clinically significant cardiovascular implications and is a standard component of TRT follow-up panels.
  • Endocrine Society guidelines (Bhasin et al., 2018) recommend testosterone level monitoring at 3 months, 6 months, and annually after TRT initiation, regardless of how you feel.
  • Standard TRT monitoring panels include more than just testosterone levels. Hematocrit, PSA, and estradiol are typically measured, and elevated hematocrit can raise clotting risk without producing any noticeable symptoms.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Endocrine Society guidelines (Bhasin et al., 2018) recommend testosterone level monitoring at 3 months, 6 months, and annually after TRT initiation, regardless of how you feel.
  • Standard TRT monitoring panels include more than just testosterone levels. Hematocrit, PSA, and estradiol are typically measured, and elevated hematocrit can raise clotting risk without producing any noticeable symptoms.
  • Gynecomastia on TRT is driven by aromatase enzyme converting testosterone to estradiol. Not every man aromatizes at the same rate, so this side effect is not universal.
  • DHT, not testosterone itself, is the primary driver of male pattern hair loss. TRT raises testosterone, which raises DHT via 5-alpha reductase, which can accelerate genetically programmed follicle miniaturization.
  • Acne on TRT is caused by androgen stimulation of sebaceous glands and is documented in dermatology literature. Most cases are manageable, but persistent or severe acne may need dermatology input, not just hormone adjustment.
  • If you have a family history of male pattern baldness, discuss this with your prescribing clinician before starting TRT, not after noticing changes.
  • The video does not cover all TRT monitoring priorities. Cardiovascular risk factors including lipid panels and hematocrit are part of responsible follow-up care and were not addressed in this clip.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Rena Malik, MD · TikTok creator

29.2K views on this video

TRT: Feeling great? Still need follow-ups! 😉 Acne, hair loss, and more. Let's check those levels regularly! #TRT #Testosterone #MensHealth #HormoneTherapy #HairLoss #renamalikmd

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Rena Malik, MD, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.